Evidence map›Paper›PMID 36703117›Full record

ArticleBMC infectious diseases2023

Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi.

Amir Kirolos, Todd D Swarthout, Andrew A Mataya, Farouck Bonomali, Comfort Brown, Jacquline Msefula, Naor Bar-Zeev, Pui-Ying Iroh Tam, Maaike Alaerts, Sithembile Bilima and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Amir KirolosDepartment of Women's and Children's Health, Faculty of Health and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. a.kirolos@liverpool.ac.uk.
Todd D SwarthoutMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Andrew A MatayaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Farouck BonomaliMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Comfort BrownMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Jacquline MsefulaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Naor Bar-ZeevInternational Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Pui-Ying Iroh TamMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Maaike AlaertsCardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Sithembile BilimaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Robert S HeydermanNIHR Mucosal Pathogens Research Unit, Division of Infection and Immunity, Research Department of Infection, University College London, London, UK.
Neil FrenchInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity of Liverpool · GBJohns Hopkins University · USLiverpool School of Tropical Medicine · GBUniversity College London · GBUniversity of Antwerp · BE

Funding

Medical Research Council MR/N023129/1Wellcome Trust 203919/Z/16/Z
6 · The paper itself

Abstract

introductionThe introduction of PCV13 to the Malawi infant immunization schedule in 2011 has been associated with reduced disease from Streptococcus pneumoniae. Improved understanding of serotypes with high invasive potential can guide future vaccination interventions. We aimed to estimate pneumococcal serotypes associated with acute respiratory infection (ARI) and invasive pneumococcal disease (IPD) in hospitalized children in Blantyre, Malawi.

methodsWe analysed data from healthy children under 5 years in the community in Blantyre and children admitted to Queen Elizabeth Central Hospital with ARI between 2015 and 2018. Nasopharyngeal swabs from children were tested for S. pneumoniae and serotyped by latex agglutination if positive. We analysed culture-positive blood and cerebrospinal fluid samples from admitted children between 2012 and 2018 to identify cases of IPD after the introduction of PCV13. We calculated the age-adjusted odds ratio (OR) of carriage for S. pneumoniae vaccine serotypes (VT) comparing those with ARI to healthy children. We also calculated age-adjusted ORs comparing serotypes causing IPD to carriage in the community with OR > 1 indicating high invasive potential.

resultsSerotypes 5 (OR 24.73 [95% CI 7.90-78.56] p < 0.001), 1 (OR 23.38 [95% CI 9.75-56.06] p < 0.001), and 6B (OR 4.73 [95% CI 1.66-11.64] p = 0.001) had high invasive potential. Serotype 6B was no longer significant (OR 1.34 [95% CI 0.07-6.87] p = 0.777) in a sensitivity analysis accounting for year of recruitment. The prevalence of S. pneumoniae carriage in the community was 72.6% [95% CI 71.3-74.0] (3078/4238) and 23.4% (719/3078) of positive community samples were VT. The carriage prevalence in those hospitalised with ARI was 45.5% [95% CI 42.1-48.9] (389/855) and 43.8% of hospital attendees reported antibiotic use prior to admission. We did not identify significant associations with carriage of any serotypes in those with ARI.

conclusionsPneumococcal serotypes 5 and 1 are associated with high invasive potential. Despite high community pneumococcal carriage, pre-hospital antibiotic usage likely reduces pneumococcal detection among children admitted in this setting and further research is needed to investigate serotypes associated with ARI. Data from this study can guide future preventative vaccination strategies in Malawi.

Indexed as

Pneumococcal InfectionsRespiratory Tract InfectionsAnti-Bacterial AgentsCarrier StateChildChild, PreschoolHumansInfantMalawiNasopharynxPneumococcal VaccinesSerogroupStreptococcus pneumoniaeAnti-Bacterial AgentsPneumococcal VaccinesAcute Respiratory InfectionInvasive Pneumococcal DiseasePneumococcus

Identifiers

PMID36703117
PMCPMC9881369
OpenAlexW4318196267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.